Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysisPaul Guedeney, Gilles Montalescot, Silvy Laporte et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2020Cited by 61
P5367Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trialsPaul Guedeney, Gilles Montalescot, Sabato Sorrentino et al.|European Heart Journal|2019Cited by 31